Clinical Trials Browser

histrelin × Clear all

NCT04513717 2026-01-14

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT05050084 2026-01-14

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Phase 3 Recruiting

Prostate Adenocarcinoma

NCT06378866 2025-12-26

DIVINE

Phase 2 Recruiting

Prostatic Neoplasms

NCT02278185 2025-05-11

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

Phase 2 Completed

19 enrolled 18 charts

Prostatic Neoplasms

NCT01013025 2024-01-02

Vantas Implant Retrieval Study

Prostatic Neoplasms

NCT01394263 2024-01-02

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT01697384 2024-01-02

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

Phase 3 Completed

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms